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Abstract. The chromatographic behavior of newly obtained derivatives of thiosemicarbazide and 1,2,4-
triazoline-5-thione was determined. The lipophilicity was confirmed by the use of the Reversed Phase 
Thin-Layer Chromatography (RP-TLC) method. For both groups of solutes the lipophilicity depended on 
the substituents. All obtained compounds were tested for their antimycotic activity. The strongest antitu-
berculosis activity was observed for 4-(2-iodophenyl)-1-(pyridine-4-ylacetyl)thiosemicarbazide 4 and 4-
phenyl-3-(pyridine-4-ylmethyl)-1,2,4-triazoline-5-thione 27. 
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INTRODUCTION 
Today, tuberculosis, right after the HIV infection,1 is a 
worldwide health threat. 30 million new cases are re-
ported each year. Statistics show that approximately 3 
million people will die annually from tuberculosis.2 For 
this reason, research into new drugs is carried out. It 
was noticed that compounds with an azole group may 
be regarded as an effective antitubercular class of drugs. 
According to reports, they inhibit bacteria by blocking 
the biosynthesis of certain bacterial lipids and/or by 
additional mechanisms.3,4 Triazole, in particular, substi-
tuted the 1,2,4-triazoles and the open-chain thiosemi-
carbazide counterparts of the 1,2,4-triazole are among 
the various heterocycles that have received the most 
attention during the last two decades as potential anti-
microbial agents.5–7 It is known that the hydrophobic 
character of substances has a major effect on biological 
activity.8 The lipophilicity of the compounds plays an 
important role in the penetration of solutes into the 
bacterial cell tissue.9 
The lipophilicity character of compounds may be 
defined in various ways. The one most frequently applied 
is a partition coefficient, P, or its decimal logarithm, log 
P, which represents the tendency of a molecule to parti-
tion itself between the organic and aqueous phases. The 
traditional “shake-flask” partition method between n-
octanol and water is often substituted by chromatographic 
approaches (Reversed-Phase High Pressure Liquid 
Chromatography (RP-HPLC) or RP-TLC methods).10–12 
It was determined for various groups of derivatives that 
thanks to using the chromatographic technique it could be 
possible to explain differences between the biological 
activity of compounds with a similar structure.13–17 This 
investigation could also suggest the strategy for the future 
synthesis of more active solutes. 
The aim of the study reported here was broad re-
search into two series of newly synthesized derivatives 
of thiosemicarbazide and 1,2,4-triazol-5-thione. These 
investigations include the determination of lipophilicity 
by the chromatographic method, as well as the antitu-
berculosis activity of solutes. 
 
EXPERIMENTAL SECTION 
All chemicals were purchased from Merck Co. or Lan-
caster (Gdańsk, Poland) and used without further purifi-
cation. Melting points were determined in a Fisher-
Johns block and were not corrected. Elemental analysis 
was made on a Perkin-Elmer 2400 CHN Analyzer and 
the data were within ± 0.4 % of the theoretical values. 
The 1H NMR spectra were recorded on a Bruker AC 
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200F instrument (300 MHz) in DMSO-d6 with TMS as 
an internal standard. The IR spectra were recorded in 
KBr on a Perkin-Elmer 1725X FTIR spectrometer. The 
purity of obtained compounds was checked by Thin-
Layer Chromatography TLC on aluminium oxide 60 
F254 plates. The solvent volume ratio in TLC mobile 
phase used for checking the purity of purchased com-
pounds was ψ(CHCl3,C2H5OH ) = 10:1 and 10:2. Detec-
tion was conducted with UV light or iodine vapor. 
Some compounds (4-9, 11, 12, 14, 16, 18-27) 
were prepared according to the procedure reported  
earlier.18–26 
 
Synthesis of thiosemicarbazides (1-8) 
A mixture of pyridine-4-acetic acid hydrazide (1.65 g, 
0.01 mol) and appropriate isothiocyanate (0.01 mol) 
was heated in an oil bath at 60–70 ºC for 15 h. The 
product was washed with diethyl ether to remove the 
unreacted isothiocyanate, filtered off and dried as well 




Yield 2.2 g (78 %); m.p. 145–148 ºC; 1H NMR (DMSO) 
δ/ppm: 3.58 (s, 2H, CH2), 7.24–7.70 (m, 4H, CHarom), 
8.46–8.51 (m, 4H, CHarom), 9.47 (s, H, NH), 9.72 (s, 1H, 
NH), 10.26 (s, 1H, NH). Anal. Calcd. for C14H13IN4OS 
(Mr = 285.34): C 58.92, H 4.59, N 19.63 %; found: C 




Yield 2.3 g (69 %); m.p. 185–187 ºC; 1H NMR (DMSO) 
δ/ppm: 3.61 (s, 2H, CH2), 7.26–7.92 (m, 4H, CHarom), 
8.21–8.52 (m, 4H, CHarom), 9.57 (s, 1H, NH), 10.05 (s, 
1H, NH), 10.37 (s, 1H, NH). Anal. Calcd. for 
C14H13N5O3S (Mr = 331.35): C 50.74, H 3.95, N 21.13 




Yield 2.3 g (73 %); m.p. 80–82 ºC; 1H NMR (DMSO) 
δ/ppm: 3.58 (s, 2H, CH2), 7.24–7.61 (m, 4H, CHarom), 
8.46–8.51 (m, 4H, CHarom), 9.72 (s, 1H, NH), 9.77 (s, 
1H, NH), 10.26 (s, 1H, NH). Anal. Calcd. for 
C14H13ClN4OS (Mr = 320.79): C 52.41, H 4.08, N 17.46 












Yield 2.36 g (82 %); m.p. 173–175 ºC. 
4-Ethyl-1-(pyridine-3-ylcarbonyl)-thiosemicarba- 
zide (7)20 




Yield 1.70 g (72 %); m.p. 190–191 ºC. 
 
Synthesis of 3,4-disubstituted-1,2,4-triazoline-5-thio- 
nes (9-12) 
A mixture of respective thiosemicarbazides (0.01 mol) 
and 2 % aqueous solution of sodium hydroxide (30 ml) 
was refluxed for 2h. The product of this reaction was 
precipitated by the addition of 3 mol L−1 dilute hydroch-








Yield 1.9 g (63 %); m.p. 225−28 ºC: 1H NMR (DMSO) 
δ/ppm: 3.98 (s, 2H, CH2), 7.07−7.71 (m, 4H, CHarom), 
8.31–8.41 (m, 4H, CHarom), 13.99 (s, 1H, NH). Anal. 
Calcd. for C14H11N5O2S (Mr = 313.33): C 53.66, H 3.53, 
















Yield 1.9 g (71 %); m.p. 225−228 ºC; 1H NMR 
(DMSO) δ/ppm: 3.90 (s, 2H, CH2), 7.30–8.39 (m, 8H, 
CHarom), 13.99 (s, 1H, NH). Anal. Calcd. for 
C14H11FN4S (Mr = 267.33): C 62.90, H 4.14, N 20.96 %; 












Yield 2.16 g (76 %); m.p. 119–121 ºC. 
 
3-Methyl-4-phenyl-1,2,4-triazoline-5-thione (20)23 
Yield 1.49 g (78 %); m.p. 220–221 ºC. 
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3-[(1-Methylpyrrol-2yl)methyl]-4-phenyl-1,2,4-
triazoline-5-thione (21)19 












Yield 1.83 g (72 %); m.p. 276–278 ºC. 
 
4-Allyl-3-(pyridine-3-yl)-1,2,4-triazoline-5-thione (25)24 




Yield 2.01 g (75 %); m.p. 128–129 ºC. 
 
Synthesis 1,3,4-trisubstituted-1,2,4-triazoline-5-thio-
ne (13, 17, 26) 
1-Allyl-4-phenyl-3-(pyridine-3-yl)-1,2,4-triazoline-5-
thione (13) 
0.23 g (0.01 gram-atom) of sodium was added to 5 ml 
of anhydrous ethanol, placed in a three-neck flask 
equipped with a reflux condenser closed with a tube of 
CaCl2. The content was mixed till sodium dissolved 
completely and then 0.01 mole 4-phenyl-3(pyridin-3-
yl)-1,2,4-triazoline-5-thione was added. Then, 0.01 
mole of allyl bromide was added drop by drop. The 
content of the flask was mixed for 4 h and left at room 
temperature for 12 h. Then, 10 ml of anhydrous ethanol 
was added and heated for 1 h. It was filtered off inor-
ganic compounds. After cooling, the precipitate was 
filtered and crystallized from ethanol. 
Yield 1.9 g (67 %); m.p. 148–150 ºC; IR (KBr) 
νmax/cm−1: 3054 (CHarom), 2943, 1411 (CHaliph), 1636 
(C=N), 1455 (C−N); 1H NMR (DMSO) δ/ppm: 5.10–
5.14 (m, 2H, CH2), 5.23–5.32 (m, 2H, CH2), 5.89–6.02 
(m, 1H, CH), 7.37–8.58 (m, 9H, CHarom). Anal. Calcd. 
for C16H14N4S (Mr=294.37): C 65.28, H 4.79, N 19.03 




2.5 g (0.01 mole) of 1-(2-hydroxyethyl)-4-ethyl-3-
(pyridin-3-yl)-1,2,4-triazoline-5-thione26 was dissolved 
in 25 ml of dry chloroform cooled (−5 ºC) and stirred. 
Then 4.8 g (0.04 mole) of freshly distilled thionyl chlo-
ride was added drop by drop. This content was mixed 
for 2 h. Later the reaction mixture was heated to mod-
erate boiling for 4 h. The solvent and the excess of 
SOCl2 were removed by distillation under reduced pres-
sure. Dry residue was then cooled and the product was 
crystallized from anhydrous ethanol. 
Yield 1.7 g (63 %); m.p. 168–170 ºC; 1H NMR (DMSO) 
δ/ppm: 1.27 (t, 3H, CH3), 3.67 (t, 2H, CH2), 3.97 (t, 2H, 
CH2), 4.07 (t, 2H, CH2), 8.17–9.20 (m, 4H, CHarom). 
Anal. Calcd. for C11H13ClN4S (Mr=268.76): C 49.15, H 




Yield 2.05 g (87 %); m.p. 145–146 ºC. 
 
Thin-layer chromatographic analysis 
Thin-layer chromatography was performed on 10 × 10 
cm TLC plates coated with RP-18 F245. Methanol-water 
mixtures were used as mobile phases. The methanol 
volume fraction was varied from 60 to 90 % in 5 % 
steps. Plates were developed to a distance of 9 cm at 
room temperature in a horizontal DS chambers 
(Chromes, Lublin, Poland) and after drying visualized 
under λ = 254 nm UV light. Each experiment was per-
formed four time. 
 
Antimycobacterial activity 
Antituberculosis activities of the synthesized com-
pounds were screened in vitro against mycobacterium 
strains: Mycobacterium smegmatis, Mycobacterium 
phlei and avirulent strain Mycobacterium H37Ra using 
the broth dilution method for determination of the Min-
imum Inhibitory Concentration (MIC) to inhibit the 
growth of microorganisms. MIC was defined as the 
highest dilution of compound required to give total 
inhibition of bacterial growth judged by the lack of 
turbidity in the tube.27 
Inocula for susceptibility testing were from a sus-
pension of microorganisms isolated earlier on Lowens-
tein medium, equivalent to a McFarland No. 1 standard. 
Turbidity of the suspension was measured using nefe-
lometer BD PhoenixSpec, Becton, Dickinson and Com-
pany USA. Then the culture was added to each vial 
containing the test drug. A control was prepared in the 
same manner as a drug containing vial. The vials with 
compounds were incubated 72 h at 37 ºC and the control 
was stored at 4 ºC. As a standard drug the Ryfampicin 
and Streptomycin were used for comparison. 
 
RESULTS AND DISCUSSION 
The thiosemicarbazide derivatives (1-8) were obtained 
in the reaction of an appropriate hydrazide carboxylic 
acid with isothiocyanates. The cyclization reaction of 
these compounds led to 3,4-disubstituted 1,2,4-
triazoline-5-thione (9-12, 14-16, 18-25, 27). In 1H NMR 
spectra of triazole derivatives the proton signals for the 
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group −NH−C=S were observed at 13.99 ppm. Some of 
cyclized products were subjected to a reaction with allyl 
bromide (13), formaldehyde (26), as well as to chloroe-
thylation (17). The signal proton characteristic for the 
−NH−C=S group, found in the 3,4-disubstituted 1,2,4-
triazoline-5-thiones, was not observed in the 1H NMR 
spectra of 1,3,4-trisubstituted triazoles. The reactions 
were performed according to Scheme 1. Structures of all 
derivatives used in this study are presented in Table 1 
and Table 2. 
The lipophilicity of chosen solutes was chromato-
graphically determined. 
The values of the retardation factor RF (the ratio of 
the migration distance of the analyte to the migration 
distance of the mobile phase) were used to calculate RM 





    
 (1) 
Relationships RM values vs. methanol volume frac-
tion in the mobile phase allowed to determine the RM0 
and φ values according to the Soczewinski-Wachtmei-
ster equation29 
M M0R R bC   (2) 
where C is the methanol volume fraction in the mobile 
phase; RM0 is the RM value obtained for pure water, φ 
was the ratio between b and RM0. 
The relative lipophilicity, expressed as RM0 values 
and the parameters obtained from the regression analy-
sis, such as the slopes (a), the correlation coefficient 
square (R2), the standard deviation of estimation (SD) 
and the values of F-test of significance (F), were listed 
in Table 3. The lipophilicity determined was in the 
range of 3.29–0.65. Comparison of the relative lipophi-
licity of a solute series revealed that higher values were 
obtained for the 1,2,4-triazoline-5-thione derivatives. 
For both groups of solutes the relative lipophilicity 
depended on the substituents (R1, R2, R3). 
The substituent in the (R2) position of thiosemi-
carbazide derivatives strongly influenced relative lipo- 
Table 1. Chemical structure of thiosemicarbazide derivatives 
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philicity. The decrease of the RM0 value was in the fol-
lowing order: 4-iodophenyl (1) > 4-chlorophenyl(3) > 
phenyl (6) > 4-nitrophenyl (2) > morpholinoethyl (5) > 
allyl (8) > ethyl (7) > 2-fluorophenyl (4). 
The second group, 1,2,4-triazoline-5-thione deriv-
atives, were divided into several subgroups. The first 
one was bearing pyridine-4-ylmethyl as R1. The relative 
lipophilicity of these compounds decreased in the fol-
lowing order: 4-methoxyphenyl (16) > 4-nitrophenyl 
(10) > 4-fluorophenyl (15) > phenyl (27) > allyl (12) > 
2-fluorophenyl (11) > ethyl (9). 
The second group possesses pyridine-3-yl as R1. 
The relative lipophilicity of these compounds decreased 
in the following order: phenyl (24) > 4-bromophenyl 
(23) > ethyl and chloroethyl (17) > allyl (25) > ethyl and 
hydroxymethyl (26). 
The third group possesses 1-methylpyrrol-2-yl-
methyl as R1. The relative lipophilicity in this group 
decreased in the following order: phenyl (21) > 4-
methoxyphenyl (18) > benzyl (19)> ethyl (22). 
The fourth group has a phenyl substituent as R2. 
The relative lipophilicity decreased in the order of pyri-
dine-3-yl and allyl (13) > pyridine-3-yl (24) > methyl 
(20) > 1,2,4-triazol-1ylmethyl (14). 
The relative lipophilicity of solutes bearing the ha-
logens changed with the increase of molecular mass of 
halogen. Among the thiosemicarbazides the highest 
lipophilicity was observed for a solute (1) with iodine, 
Table 3. Parameters of the linear correlations between the RM values of the solutes of investigated compounds and the volume 
fraction of methanol in the mobile phase and the statistic parameters (R2 – correlation coefficient square; F-test of significance, 
n = 7; SD-standard deviation of estimation) 
No −a R2 RM0 −φ F SD 
1 0.026±0.008 0.9261 2.104±0.008 0.012   62.64 0.0868 
2 0.016±0.006 0.9146 1.168±0.417 0.013   53.57 0.0567 
3 0.019±0.004 0.9682 1.420±0.302 0.013 152.40 0.0411 
4 0.012±0.002 0.9692 0.645±0.182 0.018 157.24 0.0248 
5 0.010±0.003 0.9296 1.035±0.244 0.010           66 0.0332 
6 0.020±0.003 0.9856 1.176±0,214 0.017 341.57 0.0291 
7 0.017±0.002 0.9878 0.668±0.165 0.026 404.82 0.0225 
8 0.020±0.004 0.9742 0.927±0.280 0.021 189.06 0.0381 
9 0.017±0.003 0.9833 0.970±0.195 0.018 294.56 0.0265 
10 0.023±0.003 0.9881 1.485±0.219 0.015 416.08 0.0298 
11 0.017±0.005 0.9369 1.024±0.394 0.017   74.21 0.0537 
12 0.017±0.004 0.9646 1.061±0.287 0.016 136.36 0.0390 
13 0.030±0.007 0.9561 2.444±0.562 0.012 108.82 0.0765 
14 0.018±0.005 0.9497 0.803±0.362 0.023   94.39 0.0492 
15 0.022±0.006 0.9541 1.379±0.424 0.016 103.86 0.0577 
16 0.024±0.004 0.9767 1.540±0.316 0.015 209.21 0.0430 
17 0.018±0.004 0.9636 1.448±0.297 0.012 132.30 0.0404 
18 0.034±0.008 0.9575 2.586±0.618 0.013 112.69 0.0841 
19 0.029±0.006 0.9657 2.039±0.469 0.014 140.66 0.0638 
20 0.024±0.009 0.9019 1.393±0.687 0.017   45.95 0.0935 
21 0.042±0.010 0.9568 3.293±0.770 0.013 110.61 0.1047 
22 0.021±0.004 0.9730 1.354±0.310 0.016 180.14 0.0422 
23 0.031±0.006 0.9754 2.235±0.424 0.014 198.09 0.0577 
24 0.025±0.002 0.9940 2.356±0.171 0.011 823.15 0.0232 
25 0.019±0.005 0.9521 1.155±0.370 0.016   99.32 0.0503 
26 0.016±0.006 0.9114 0.943±0.437 0.017   51.43 0.0595 
27 0.019±0.003 0.9817 1.112±0.222 0.017 268.11 0.0303 
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the smallest for fluorine (4). Among the 1,2,4-triazoline-
5-thiones the highest lipophilicity was observed for a 
solute possessing bromine (23), the smallest for fluorine 
(11). Also the position of fluorine in the phenyl ring in-
fluence RM0 values. The highest was observed when 
fluorine was in position 4 (compare solutes 15 and 11). 
The examples of the correlation between the RM values 
and the methanol volume fraction in the mobile phase 
for solutes 4, 15, 17, 21 was presented in Figure 1. 
The higher RM0 values indicate greater lipophilici-
ty. Arranging the solutes in the order of decreasing 
lipophilicity resulted in the following list: 
21>18>13>24>23>1>19>16>17>10>3>20>22>15
>6>2>25>27>12>5>11>9> 26>8>14>7>4 
The in vitro antituberculosis activities of all com-
pounds were evaluated against mycobacterium strains: 
Mycobacterium smegmatis, Mycobacterium phlei and 
Mycobacteium H37Ra using the broth dilution method. 
According to our results, some of them showed promis-
ing antituberculosis activity against Mycobacterium 
phlei (Table 4). The most effective derivatives possess a 
2-fluorophenyl substituent of 1-(pyridine-4-ylacetyl)-




The lipohilicity of newly obtained derivatives of thi-
osemicarbazides and 1,2,4-triazoline-5-thiones were 
determined by thin-layer chromatography method. The 
smallest values were determined for 3-[(1-methylpyrrol-
2-yl)methyl]-4-phenyl-1,2,4-triazoline-5-thione (21). 
The highest values of lipophilicity were determined for 
4-(2-fluorophenyl)-1-(pyridine-4-ylacetyl)-
thiosemcarbazide (4). 
The biological activity of newly synthesized com-
pounds against Mycobacterium sp. was investigated. 
The highest antituberculosis activity was observed 
against Mycobacterium pheli. The minimum inhibitory 
concentration of the solute (4) and (27) was similar to 
Streptomycin (standard). The results obtained will be 
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Figure 1. The examples of correlations between the RM values
and methanol volume fraction in the mobile phase for solutes
4, 15, 17, 21. 
Table 4. Antituberculosis activities of obtained compounds 
Minimum inhibitory concentration /μg ml−1 
Comp. M. smegmatis M. Phlei M. H37Ra 
    4 R(a) 128 256 
  10 R(a) 256 R(a) 
  26 256 256 512 
  27 256 128 R(a) 
  Streptomycin 64 128 32 
  Rifampicin 64 32 32 
(a) 1000 g = R (resistant) 
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Određena su kromatografska svojstva novo dobivenih derivata tiosemikarbazida i 1,2,4-triazolin-5-tiona. Lipofil-
nost je potvrđena korišteći metodu reverzno-fazne tankoslojne kromatografije (engl. Reversed Phase Thin-Layer 
Chromatography (RP-TLC)). Za obje skupine otopljenih tvari lipofilnost je ovisila o supstituentima. Svi dobiveni 
spojevi su bili testirani za antimikotsku aktivnost. Najjača antituberkulozna aktivnost je uočena za 4-(2-jodofenil)-
1-(piridin-4-ilacetil)tiosemikarbazid 4 i 4-fenil-3-(piridin-4-ilmetil)-1,2,4-triazolin-5-tion 27. 
